Drug Chatter -- Tracking biopharma stock chatter

Profile for AcelRx Pharmaceuticals, Inc. (ACRX)

« Back to company index

ACRX Chatter Timeline

Stock Ticker for ACRX

Most Active Tweeters for ACRX

UserTweets
@stocknewstimes 9
@ConsumerFeed 7
@filingBot 6
@CFinancialNews 5
@AmericanBanking 4

Recent Tweets for ACRX

ZolmaxNews @ZolmaxNews
AcelRx Pharmaceuticals, Inc. $ACRX Trading Up 7.9% on Insider Buying Activity https://t.co/4g566cbIa7
November 16th 2017, 6:11pm
alphabetastock @alphabetastock
Day Traders Must Read Before Invest: AcelRx Pharmaceuticals Inc $ACRX https://t.co/fbvkZBeoaJ
November 16th 2017, 4:11pm
MaisaCorp @MaisaCorp
$ACRX Sufentanil Sublingual Well-Tolerated in Management of Moderate-to-Severe Acute Pain
November 16th 2017, 3:11pm
SaadeyBajar @SaadeyBajar
$ACRX some decent move finally after the latest FDA denial. Hopefully some good news and new buyers in few weeks to come. Good luck.
November 16th 2017, 2:11pm
wininstocks2014 @wininstocks2014
AcelRx Pharmaceuticals Inc. $ACRX Stock Live Analysis 11-08-2017 #stock https://t.co/vXpGScHHCH
November 16th 2017, 12:11pm
AlertTrade @AlertTrade
VOLUME RADAR ALERT: $ACRX ACELRX PHARMACEUTICALS ? TradeIdeas via https://t.co/VS8RO1bzXJ to Free Trading Room
November 16th 2017, 11:11am
IntensityStocks @IntensityStocks
$ACRX $2.15 +13.2% ON 811K VOL [PRICE-ACTION/VOLATILITY ALERT] https://t.co/woAZX0NtIw
November 16th 2017, 10:11am
stocknewstimes @stocknewstimes
Somewhat Positive News Coverage Somewhat Unlikely to Impact AcelRx Pharmaceuticals $ACRX Stock Price https://t.co/JZiNU9xlbp
November 16th 2017, 10:11am
Briefingcom @Briefingcom
$ACRX: AcelRx announces 'publication of a manuscript analyzing sufentanil sublingual tablet 30 mcg for postoperativ… https://t.co/dVP5AV6lVI
November 16th 2017, 9:11am
ProTradersNews @ProTradersNews
$ACRX: AcelRx Pharmaceuticals Reports Publication of Manuscript …: https://t.co/gLV52ctnWS
November 16th 2017, 7:11am
Traderideas1 @Traderideas1
RT @odibro: $ACRX Reports Publication of Manuscript Analyzing Sufentanil Sublingual Tablets in Patients with Postoperative Pain https://t.c…
November 16th 2017, 7:11am
odibro @odibro
$ACRX Reports Publication of Manuscript Analyzing Sufentanil Sublingual Tablets in Patients with Postoperative Pain https://t.co/nIibjdckHw
November 16th 2017, 7:11am
Allstocknews @Allstocknews
$ACRX AcelRx Pharmaceuticals Reports Publication of Manuscript Analyzing Sufentanil Sublingual Tablets in Pat From our Stock News Alerts App
November 16th 2017, 7:11am
intercooleronli @intercooleronli
FY2017 EPS Estimates for AcelRx Pharmaceuticals, Inc. Boosted by Analyst $ACRX https://t.co/CXLptDxDAK
November 16th 2017, 6:11am
ConsumerFeed @ConsumerFeed
FY2017 EPS Estimates for AcelRx Pharmaceuticals, Inc. Boosted by Analyst $ACRX https://t.co/9CLNoHrCB6 #acn
November 16th 2017, 5:11am
CFinancialNews @CFinancialNews
FY2017 EPS Estimates for AcelRx Pharmaceuticals, Inc. Boosted by Analyst $ACRX https://t.co/RO7Xyj9SYH
November 16th 2017, 5:11am
dakotafinancial @dakotafinancial
FY2017 EPS Estimates for AcelRx Pharmaceuticals, Inc. Boosted by Analyst $ACRX https://t.co/eX7mN1gHyG
November 16th 2017, 5:11am
WKRBNews @WKRBNews
AcelRx Pharmaceuticals, Inc. $ACRX Sees Significant Growth in Short Interest https://t.co/4APExFKkeh
November 16th 2017, 4:11am
dailymailtimes @dailymailtimes
AcelRx Pharmaceuticals, Inc. $ACRX Sees Significant Growth in Short Interest https://t.co/yOlKBlCQAa
November 16th 2017, 4:11am
dailypoliticaln @dailypoliticaln
AcelRx Pharmaceuticals, Inc. $ACRX Sees Significant Growth in Short Interest https://t.co/F1bZSWd0GC
November 16th 2017, 4:11am
midetimes @midetimes
AcelRx Pharmaceuticals, Inc. $ACRX Sees Significant Growth in Short Interest https://t.co/1WPb9qIHF4
November 16th 2017, 4:11am
ledgerzette @ledgerzette
Head-To-Head Analysis: AcelRx Pharmaceuticals $ACRX and Versartis $VSAR https://t.co/r0JsEz2rE7
November 15th 2017, 9:11pm
ZolmaxNews @ZolmaxNews
AcelRx Pharmaceuticals, Inc. $ACRX Receives $5.00 Average Target Price from Analysts https://t.co/XTdm621b01
November 15th 2017, 3:11pm
dispatchtribune @dispatchtribune
AcelRx Pharmaceuticals, Inc. $ACRX Receives $5.00 Average Target Price from Analysts https://t.co/xKJ87LLPzE
November 15th 2017, 3:11pm
alphabetastock @alphabetastock
AcelRx Pharmaceuticals, Inc. $ACRX – Hair-Raising Facts to Know https://t.co/bbdVUHtAjB
November 15th 2017, 11:11am
intercooleronli @intercooleronli
Mark G. Edwards Acquires 30,000 Shares of AcelRx Pharmaceuticals, Inc. $ACRX Stock https://t.co/tlsYs6oef8
November 15th 2017, 10:11am
CFinancialNews @CFinancialNews
Mark G. Edwards Acquires 30,000 Shares of AcelRx Pharmaceuticals, Inc. $ACRX Stock https://t.co/JvG1UwMZrM
November 15th 2017, 10:11am
ConsumerFeed @ConsumerFeed
Mark G. Edwards Acquires 30,000 Shares of AcelRx Pharmaceuticals, Inc. $ACRX Stock https://t.co/nrcC3fMrmr #acn
November 15th 2017, 10:11am
AmericanBanking @AmericanBanking
AcelRx Pharmaceuticals Director Mark Edwards Buys $57,000.00 in $ACRX https://t.co/raizqoZyEJ
November 15th 2017, 10:11am
ConsumerFeed @ConsumerFeed
AcelRx Pharmaceuticals Director Mark Edwards Buys $57,000.00 in $ACRX https://t.co/D3IHdiLK5o
November 15th 2017, 10:11am
InsiderAlertsIA @InsiderAlertsIA
$ACRX: New Insider Filing on Director MARK G EDWARDS: https://t.co/nP0jw3rgQx
November 15th 2017, 9:11am
SpeedyCalls @SpeedyCalls
Insider Alert: EDWARDS MARK G buys $ACRX for 57K
November 15th 2017, 7:11am
StockTexts @StockTexts
$ACRX AcelRx Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/LlZBVPH5dq
November 15th 2017, 7:11am
filingBot @filingBot
@altafmubaraki there is a new form 4 filing for $ACRX https://t.co/PGyHCKjKZI Share with your friends!
November 15th 2017, 7:11am
filingBot @filingBot
@swonger7 there is a new form 4 filing for $ACRX https://t.co/PGyHCKBlRg Please RT.
November 15th 2017, 7:11am
6yi @6yi
$ACRX PK of Zalviso 15mcg/20min for 13 hours. Dsuvia 30mcg/hour maximum dose issue in CRL shouldn't be a problem. https://t.co/rplMrmFCqF
November 15th 2017, 6:11am
dailymailtimes @dailymailtimes
Brokerages Expect AcelRx Pharmaceuticals, Inc. $ACRX Will Announce Earnings of -$0.21 Per Share https://t.co/vEhKBgteyS
November 14th 2017, 7:11pm
midetimes @midetimes
Brokerages Expect AcelRx Pharmaceuticals, Inc. $ACRX Will Announce Earnings of -$0.21 Per Share https://t.co/dKy9593v8W
November 14th 2017, 7:11pm
dailypoliticaln @dailypoliticaln
Brokerages Expect AcelRx Pharmaceuticals, Inc. $ACRX Will Announce Earnings of -$0.21 Per Share https://t.co/OZRYb739cm
November 14th 2017, 7:11pm
WKRBNews @WKRBNews
Brokerages Expect AcelRx Pharmaceuticals, Inc. $ACRX Will Announce Earnings of -$0.21 Per Share https://t.co/MBC1mzDiLI
November 14th 2017, 7:11pm
CFinancialNews @CFinancialNews
Brokerages Expect AcelRx Pharmaceuticals, Inc. $ACRX Will Announce Earnings of -$0.21 Per Share https://t.co/CbWRo7CiIK
November 14th 2017, 7:11pm
ConsumerFeed @ConsumerFeed
Brokerages Expect AcelRx Pharmaceuticals, Inc. $ACRX Will Announce Earnings of -$0.21 Per Share https://t.co/f27nPribk1 #acn
November 14th 2017, 7:11pm
InsiderAlertsIA @InsiderAlertsIA
$ACRX: New Insider Filing on Chief Financial Officer RAFFI ASADORIAN: https://t.co/iyEc33MGII
November 14th 2017, 9:11am
WatchlistN @WatchlistN
Somewhat Favorable Media Coverage Somewhat Unlikely to Impact AcelRx Pharmaceuticals $ACRX Share Price https://t.co/O5tve0fwXQ
November 14th 2017, 8:11am
AmericanBanking @AmericanBanking
AcelRx Pharmaceuticals CFO Raffi Asadorian Buys $9,700.00 in $ACRX https://t.co/wk7DHv6HFH
November 14th 2017, 7:11am
UndrGroundTrade @UndrGroundTrade
RT @AnalystWire: AcelRx Pharmaceuticals $ACRX PT Lowered to $2 at Jefferies https://t.co/K16UggIvH9
November 14th 2017, 7:11am
LargeVoidBot @LargeVoidBot
$ACRX Nov 13, CFO Buys 5000 Shrs; Net: 9.71k; Acq'd: 5000 1.94/s; Disp'd: 0 https://t.co/aVzzGcpkSB
November 14th 2017, 7:11am
wlstcom @wlstcom
AcelRx Pharmaceuticals ACRX PT Lowered to $2 at Jefferies $ACRX https://t.co/S6DviHMrfm https://t.co/4aI09W80l0 https://t.co/LVDBf61BUv
November 14th 2017, 7:11am
AnalystWire @AnalystWire
AcelRx Pharmaceuticals $ACRX PT Lowered to $2 at Jefferies https://t.co/K16UggIvH9
November 14th 2017, 7:11am
StockTexts @StockTexts
$ACRX AcelRx Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/bzQBO2hgPO
November 14th 2017, 7:11am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.